The ongoing COVID-19 pandemic caused by SARS-CoV-2 infection has threatened global
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …

The ongoing SARS-CoV-2 pandemic is controlled but not halted by public health measures
and mass vaccination strategies which have exclusively relied on intramuscular vaccines …

A series of recombinant human type 5 adenoviruses that express the full-length or
membrane-truncated spike protein (S) of SARS-CoV-2 (AdCoV2-S or AdCoV2-SdTM …

The coronavirus disease 2019 (COVID-19) pandemic has highlighted the urgent need for
effective prophylactic vaccination to prevent the spread of severe acute respiratory …

The emerging SARS-CoV-2 variants of concern (VOCs) threaten the effectiveness of current
COVID-19 vaccines administered intramuscularly and designed to only target the spike …

The world is in need of next-generation COVID-19 vaccines. Although first-generation
injectable COVID-19 vaccines continue to be critical tools in controlling the current global …

There is an urgent need to develop efficacious vaccines against SARS-CoV-2 that also
address the issues of deployment, equitable access, and vaccine acceptance. Ideally, the …

ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic has illustrated the critical
need for effective prophylactic vaccination to prevent the spread of severe acute respiratory …

The coronavirus disease 2019 (COVID-19) pandemic has highlighted the urgent need for
effective prophylactic vaccination to prevent the spread of severe acute respiratory …

Mucosal vaccination appears to be suitable to protect against SARS-CoV-2 infection. In this
study, we tested an intranasal mucosal vaccine candidate for COVID-19 that consisted of a …